Hereditary hemorrhagic telangiectasia/avastin
Copyright policy )Hereditary hemorrhagic telangiectasia/avastin
Abstract This is the first scientific report of hereditary hemorrhagic telangiectasia (HHT) epistaxis treatment by intranasal spraying of the vascular endothelial growth factor (VEGF) inhibitor bevacizumab (Avastin). Epistaxis in patients with HHT is a morbid, mortal condition that is difficult and unpleasant to manage. Nasal telangiectasia growth is modulated by VEGF, which is elevated in HHT patients. Bevacizumab is a VEGF inhibitor that diminishes epistaxis when administered intravenously or injected locally, or as reported here when sprayed topically onto the nasal mucosa. Laryngoscope, 2010
- University of Missouri United States
- VA San Diego Healthcare System United States
- University of Kansas United States
- Veterans Health Administration United States
Male, Vascular Endothelial Growth Factor A, Antibodies, Monoclonal, Angiogenesis Inhibitors, Middle Aged, Antibodies, Monoclonal, Humanized, Bevacizumab, Epistaxis, Humans, Telangiectasia, Hereditary Hemorrhagic, Administration, Intranasal
Male, Vascular Endothelial Growth Factor A, Antibodies, Monoclonal, Angiogenesis Inhibitors, Middle Aged, Antibodies, Monoclonal, Humanized, Bevacizumab, Epistaxis, Humans, Telangiectasia, Hereditary Hemorrhagic, Administration, Intranasal
selected citations These citations are derived from selected sources.This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).51 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Top 10% influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Top 10% impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Top 10%
Citations provided by BIP!Popularity provided by BIP!